Portfolio company
Elastrin
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops nanoparticle therapies targeting damaged elastin to reverse tissue calcification for patients with cardiovascular and age-related diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cyclarity
This biopharmaceutical company develops engineered cyclodextrin molecules to remove arterial plaque and treat age-related vascular diseases for patients with atherosclerosis and heart conditions.
NanoPhoria
This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.
DRUG-COATED BALLOON (DCB)
This company develops nanoparticle-based dual-drug-coated balloons for interventional cardiologists to treat coronary and peripheral artery disease without permanent implants.
Immutrin
This biotechnology company develops antibody therapies to remove amyloid deposits and treat cardiomyopathy for patients with amyloidosis.
Neotis
This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.
VASCULAR THERAPIES
This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.
NaNotics
This biopharmaceutical company develops subtractive nanoparticles that capture and clear pathogenic molecules from the blood to treat cancer and inflammatory diseases in humans and dogs.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
